Vera Therapeutics discloses minimal exposure to Silicon Valley Bank failure

Vera Therapeutics, Inc.

Company holds approximately 1.2% of its cash and investments at SVB.
SVB closed and FDIC appointed as receiver; Vera considers risk minimal.
Vera expects no material impact on operations or liquidity from this exposure.

item 8.01

Vera Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-067568

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.